Labial Biopsy in Patients With Tuberculosis Disease
NCT02115854 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 65
Last updated 2014-04-16
Summary
The distinction between Tuberculosis disease (TB), a worldwide infective granulomatosis requiring long-term antibiotic treatment, and sarcoïdosis, a rare granulomatous disease successfully treated with high dose steroids is not straightforward and may delay the treatment choice by the physician.
The goal was to evaluate prospectively and consecutively the presence of epithelioid granulomas in salivary glands biopsy of patients with TB.
Conditions
- Tuberculosis
- Sarcoidosis
Interventions
- OTHER
-
labial biopsy
Sponsors & Collaborators
-
Hopital Lariboisière
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-12-31
- Primary Completion
- 2014-04-30
Countries
- France
Study Locations
More Related Trials
-
Efficacy of Antituberculous Therapy in Management of Sarcoidosis
NCT01245036 ·Status: COMPLETED ·Phase: NA
-
Improving the Diagnostic of Tuberculosis
NCT02861768 ·Status: COMPLETED ·Phase: NA
-
The Usefulness of Interferon-γ Release Assays and Tuberculin Skin Test for Detection of Latent Tuberculosis Infection
NCT01685905 ·Status: UNKNOWN
-
Clinical Presentation, and Treatment Outcomes in Tuberculous Patients in Sohag Governorate
NCT06141148 ·Status: RECRUITING
-
Study of Latent Tuberculosis Infection (LTBI) by High Resolution Scanner
NCT00904956 ·Status: UNKNOWN
-
Clinical Evaluation of an IGRA Test for the Diagnosis of Active and Latent Tuberculosis
NCT06485895 ·Status: RECRUITING ·Phase: NA
-
Effects of Interferon-Gamma on Cavitary Pulmonary Tuberculosis in the Lungs
NCT00201123 ·Status: COMPLETED ·Phase: PHASE2
-
Prevalence of Latent Tuberculosis (TB) Infection Diagnosed by Interferon-gamma Release Assay and Tuberculin Skin Tests in Patients With Old Healed TB
NCT01099098 ·Status: COMPLETED
-
A Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of TBA-354 in Healthy Adult Subjects
NCT02288481 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate the Efficacy of GlaxoSmithKline (GSK) Biologicals' Candidate Tuberculosis (TB) Vaccine in Adults
NCT01755598 ·Status: COMPLETED ·Phase: PHASE2
-
New Strategies for Assessment of the Persistence of Viable Bacilli in Latent and Active Tuberculosis
NCT05621343 ·Status: RECRUITING
-
Evaluation of a Novel Microbiological Diagnostic Test for Latent Mycobacterium Tuberculosis Infection
NCT06728930 ·Status: ENROLLING_BY_INVITATION
-
ESAT6/CFP10 Skin Testing for TB Infection in Rheumatologic Patients
NCT06796647 ·Status: RECRUITING
-
Study of TB Lesions Obtained in Therapeutical Surgery
NCT02715271 ·Status: COMPLETED
-
Immune Responses to Mycobacterium Tuberculosis (Mtb) in People With Latent Tuberculosis Infection With or Without Concomitant Helminth Infection
NCT02225158 ·Status: TERMINATED
-
Perfusion Analysis Using Rubidium in Cardiac Sarcoidosis
NCT01648933 ·Status: COMPLETED ·Phase: NA
-
Expression of Tuberculosis in the Lung
NCT00201253 ·Status: COMPLETED
-
Study to Evaluate H56:IC31 in Preventing Rate of TB Recurrence
NCT03512249 ·Status: COMPLETED ·Phase: PHASE2
-
Latent Tuberculosis Infection in Bone Marrow Transplant Recipients
NCT01021124 ·Status: COMPLETED
-
Paradoxical Reactions in Non Immuno-compromized Patients With Extrapulmonary Tuberculosis
NCT01252992 ·Status: COMPLETED
-
Efficacy and Safety of Immunomodulator as an Adjunct Therapy in New Pulmonary Tuberculosis(Category I) Patients.
NCT00341328 ·Status: COMPLETED ·Phase: PHASE3
-
Training Protocol on the Natural History of Tuberculosis
NCT01212003 ·Status: RECRUITING
-
Evaluation of Tuberculosis Treatment Outcomes
NCT06942975 ·Status: COMPLETED
-
Treatment Outcome Between Mycobacterium Abscessus Infection in Chronic Lung Disease and Acquired Interferon-gamma Autoantibody Syndrome
NCT05354583 ·Status: COMPLETED
-
Demonstration of the Dynamic Hypothesis of Latent Tuberculosis Infection
NCT00905970 ·Status: UNKNOWN